{"id":"https://openalex.org/W2001815276","doi":"https://doi.org/10.1517/14740330802423291","title":"Safety of peginterferon in the treatment of chronic hepatitis C","display_name":"Safety of peginterferon in the treatment of chronic hepatitis C","publication_year":2008,"publication_date":"2008-11-01","ids":{"openalex":"https://openalex.org/W2001815276","doi":"https://doi.org/10.1517/14740330802423291","mag":"2001815276","pmid":"https://pubmed.ncbi.nlm.nih.gov/18983223"},"language":"en","primary_location":{"id":"doi:10.1517/14740330802423291","doi":"https://doi.org/10.1517/14740330802423291","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14740330802423291","pdf_url":null,"source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108716819","display_name":"Nikroo Hashemi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikroo Hashemi","raw_affiliation_strings":["Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA","Fellow Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I149251103"]},{"raw_affiliation_string":"Fellow Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101437957","display_name":"Simona Rossi","orcid":"https://orcid.org/0000-0002-2733-5615","observed_orcids":["https://orcid.org/0000-0002-2733-5615"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Simona Rossi","raw_affiliation_strings":["Clinical Assistant Professor of Medicine Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Assistant Professor of Medicine Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031231657","display_name":"Victor J. Navarro","orcid":"https://orcid.org/0000-0002-8428-8528","observed_orcids":["https://orcid.org/0000-0002-8428-8528"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor J Navarro","raw_affiliation_strings":["Professor of Medicine, Medical Director for Liver Transplantation Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Professor of Medicine, Medical Director for Liver Transplantation Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025326920","display_name":"Steven K. Herrine","orcid":"https://orcid.org/0000-0001-5763-1821","observed_orcids":["https://orcid.org/0000-0001-5763-1821"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven K Herrine","raw_affiliation_strings":["Professor of Medicine Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA +1 215 955 8900; +1 215 503 2146; steven.herrine@jefferson.edu","+1 215 503 2146","Professor of Medicine Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA +1 215 955 8900"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Professor of Medicine Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA +1 215 955 8900; +1 215 503 2146; steven.herrine@jefferson.edu","institution_ids":["https://openalex.org/I149251103"]},{"raw_affiliation_string":"+1 215 503 2146","institution_ids":[]},{"raw_affiliation_string":"Professor of Medicine Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA +1 215 955 8900","institution_ids":["https://openalex.org/I149251103"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I149251103"],"apc_list":null,"apc_paid":null,"fwci":0.1112,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.12079511,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"7","issue":"6","first_page":"771","last_page":"781"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegylated-interferon","display_name":"pegylated interferon","score":0.8989999890327454},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9359999895095825},{"id":"https://openalex.org/keywords/pegylated-interferon-alpha","display_name":"pegylated interferon-alpha","score":0.7459999918937683},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9679999947547913},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6489999890327454},{"id":"https://openalex.org/keywords/side-effect-management","display_name":"side effect management","score":0.7549999952316284},{"id":"https://openalex.org/keywords/combination-antiviral-therapy","display_name":"combination antiviral therapy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.8560000061988831},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.48100000619888306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9336258172988892},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.8639618158340454},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8220995664596558},{"id":"https://openalex.org/C41260117","wikidata":"https://www.wikidata.org/wiki/Q668064","display_name":"Hepatology","level":2,"score":0.6621989607810974},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.635465681552887},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.5770382881164551},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5644077658653259},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.5639662146568298},{"id":"https://openalex.org/C3454156","wikidata":"https://www.wikidata.org/wiki/Q1144241","display_name":"Side effect (computer science)","level":2,"score":0.5584166049957275},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.4218134582042694},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36019736528396606},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3574034571647644},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18909797072410583},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.07696017622947693},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055118","descriptor_name":"Medication Adherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/14740330802423291","doi":"https://doi.org/10.1517/14740330802423291","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14740330802423291","pdf_url":null,"source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},{"id":"pmid:18983223","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18983223","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug safety","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":100,"referenced_works":["https://openalex.org/W8805440","https://openalex.org/W55353898","https://openalex.org/W73123045","https://openalex.org/W118635100","https://openalex.org/W165110432","https://openalex.org/W177166390","https://openalex.org/W1480119358","https://openalex.org/W1559260987","https://openalex.org/W1564673376","https://openalex.org/W1572484072","https://openalex.org/W1592725066","https://openalex.org/W1773121489","https://openalex.org/W1805116264","https://openalex.org/W1928458446","https://openalex.org/W1969178220","https://openalex.org/W1970053808","https://openalex.org/W1972862906","https://openalex.org/W1973269763","https://openalex.org/W1974932469","https://openalex.org/W1975782665","https://openalex.org/W1978859946","https://openalex.org/W1979517436","https://openalex.org/W1983160959","https://openalex.org/W1984004040","https://openalex.org/W1985241178","https://openalex.org/W1985413304","https://openalex.org/W1986087981","https://openalex.org/W1991643675","https://openalex.org/W1997041955","https://openalex.org/W1998859748","https://openalex.org/W2000331845","https://openalex.org/W2000676831","https://openalex.org/W2001266005","https://openalex.org/W2001409871","https://openalex.org/W2005740971","https://openalex.org/W2006159673","https://openalex.org/W2007217713","https://openalex.org/W2007487698","https://openalex.org/W2010176958","https://openalex.org/W2011809148","https://openalex.org/W2014282491","https://openalex.org/W2018896573","https://openalex.org/W2020347377","https://openalex.org/W2025098916","https://openalex.org/W2027545702","https://openalex.org/W2034654277","https://openalex.org/W2035906120","https://openalex.org/W2037029052","https://openalex.org/W2037620406","https://openalex.org/W2040254809","https://openalex.org/W2040279923","https://openalex.org/W2042320906","https://openalex.org/W2044845383","https://openalex.org/W2047329659","https://openalex.org/W2047335290","https://openalex.org/W2048228183","https://openalex.org/W2049932899","https://openalex.org/W2050052235","https://openalex.org/W2055155510","https://openalex.org/W2064826311","https://openalex.org/W2064870615","https://openalex.org/W2067855438","https://openalex.org/W2070478353","https://openalex.org/W2072160870","https://openalex.org/W2073809870","https://openalex.org/W2078994429","https://openalex.org/W2080970660","https://openalex.org/W2081831173","https://openalex.org/W2093850082","https://openalex.org/W2094525616","https://openalex.org/W2102280593","https://openalex.org/W2107044757","https://openalex.org/W2113526866","https://openalex.org/W2117903190","https://openalex.org/W2118618370","https://openalex.org/W2125583607","https://openalex.org/W2127685726","https://openalex.org/W2132937518","https://openalex.org/W2135292120","https://openalex.org/W2136397584","https://openalex.org/W2138529156","https://openalex.org/W2141559815","https://openalex.org/W2141779237","https://openalex.org/W2142337801","https://openalex.org/W2156574153","https://openalex.org/W2158811343","https://openalex.org/W2159205658","https://openalex.org/W2159847907","https://openalex.org/W2161295839","https://openalex.org/W2164722289","https://openalex.org/W2166407844","https://openalex.org/W2168079080","https://openalex.org/W2169630838","https://openalex.org/W2172292246","https://openalex.org/W2344257853","https://openalex.org/W2383855941","https://openalex.org/W2407904560","https://openalex.org/W2419353475","https://openalex.org/W4232907328","https://openalex.org/W4237105576"],"related_works":["https://openalex.org/W2094239322","https://openalex.org/W2007740030","https://openalex.org/W1975620628","https://openalex.org/W7095918064","https://openalex.org/W1502161309","https://openalex.org/W2025524023","https://openalex.org/W2351880459","https://openalex.org/W2072160870","https://openalex.org/W2314626936","https://openalex.org/W2186964192"],"abstract_inverted_index":{"BACKGROUND:":[0],"Combination":[1],"of":[2,11,27,40,51,56,109],"'pegylated'":[3],"interferons":[4],"(IFNs)":[5],"plus":[6],"ribavirin,":[7],"the":[8,47,54],"standard":[9],"treatment":[10,55],"chronic":[12],"hepatitis":[13],"C":[14],"(CHC),":[15],"is":[16,115],"frequently":[17],"associated":[18],"with":[19,36,97],"side":[20,29,48,113],"effects.":[21],"Anticipation,":[22],"recognition":[23],"and":[24,38,60,76,88,103],"proper":[25],"management":[26],"these":[28],"effects":[30,114],"are":[31],"important":[32],"to":[33,112],"ensure":[34],"compliance":[35],"therapy":[37,99,110],"achievement":[39],"sustained":[41],"virologic":[42],"response.":[43],"OBJECTIVE:":[44],"To":[45],"illustrate":[46],"effect":[49],"profile":[50],"pegIFN-alpha":[52],"in":[53,81,118],"CHC.":[57,77],"METHODS:":[58],"Studies":[59],"abstracts":[61],"were":[62],"identified":[63],"through":[64],"a":[65],"computerized,":[66],"English":[67],"language":[68],"literature":[69],"search.":[70],"Key":[71],"search":[72],"terms":[73],"included":[74],"peginterferon":[75],"Information":[78],"available":[79],"only":[80],"abstract":[82],"form":[83],"was":[84],"retrieved":[85],"from":[86],"national":[87],"international":[89],"hepatology":[90],"associations.":[91],"RESULTS:":[92],"Most":[93],"adverse":[94],"events":[95],"occurring":[96],"combination":[98],"can":[100],"be":[101],"anticipated":[102],"managed":[104],"appropriately;":[105],"therefore,":[106],"premature":[107],"discontinuation":[108],"owing":[111],"not":[116],"required":[117],"most":[119],"patients.":[120]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}